Haemonetics Corporation Accretion Expense
Haemonetics Corporation (HAE) reported Accretion Expense of -$416.00 thousand for the 12-month period ending 2011-04-02, per its 10-K filed 2011-05-26.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AccretionExpense · last filed 2011-05-26
- Haemonetics Corporation accretion expense for the quarter ending 2011-04-02 was $0.00.
- Haemonetics Corporation accretion expense for the quarter ending 2011-01-01 was $77.00K, a 65.47% decline year-over-year.
- Haemonetics Corporation accretion expense for the quarter ending 2010-10-02 was -$658.00K, a 416.35% decline year-over-year.
- Haemonetics Corporation accretion expense for the quarter ending 2010-07-03 was $165.00K, a 17.50% decline year-over-year.
- Haemonetics Corporation accretion expense for fiscal 2011 was -$416.00K, a 170.75% decline from fiscal 2010.
- Haemonetics Corporation accretion expense for fiscal 2010 was $588.00K.
| Period end | Accretion Expense 3 month | Accretion Expense 6 month | Accretion Expense 9 month | Accretion Expense 12 month |
|---|---|---|---|---|
| 2011-04-02 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2011-05-26 | $77.00K derived: sum of 2 quarters · filed 2011-05-26 | -$581.00K derived: sum of 3 quarters · filed 2011-05-26 | -$416.00K 10-K · filed 2011-05-26 |
| 2011-01-01 | $77.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-02-08 | -$581.00K derived: sum of 2 quarters · filed 2011-02-08 | -$416.00K 10-Q · filed 2011-02-08 | -$459.00K derived: sum of 4 quarters · filed 2011-05-26 |
| 2010-10-02 | -$658.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2010-11-10 | -$493.00K 10-Q · filed 2010-11-10 | -$536.00K derived: sum of 3 quarters · filed 2011-05-26 | -$313.00K derived: sum of 4 quarters · filed 2011-05-26 |
| 2010-07-03 | $165.00K 10-Q · filed 2010-08-11 | $122.00K derived: sum of 2 quarters · filed 2011-05-26 | $345.00K derived: sum of 3 quarters · filed 2011-05-26 | $553.00K derived: sum of 4 quarters · filed 2011-05-26 |
| 2010-04-03 | -$43.00K derived: 10-K 12 month − 10-Q 9 month · filed 2011-05-26 | $180.00K derived: sum of 2 quarters · filed 2011-05-26 | $388.00K derived: sum of 3 quarters · filed 2011-05-26 | $588.00K 10-K · filed 2011-05-26 |
| 2009-12-26 | $223.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-02-08 | $431.00K derived: sum of 2 quarters · filed 2011-02-08 | $631.00K 10-Q · filed 2011-02-08 | |
| 2009-09-26 | $208.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2010-11-10 | $408.00K 10-Q · filed 2010-11-10 | ||
| 2009-06-27 | $200.00K 10-Q · filed 2010-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| PULSE BIOSCIENCES, INC. (PLSE) | United States | $3.696B | -24.47 |
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |